Filing Details

Accession Number:
0001415889-22-000350
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-05 15:12:06
Reporting Period:
2022-01-04
Accepted Time:
2022-01-05 15:12:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818844 Virios Therapeutics Inc. VIRI Pharmaceutical Preparations (2834) 854314201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1825986 R David Keefer C/O Virios Therapeutics, Inc.
44 Milton Avenue
Alpharetta GA 30009
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-04 5,000 $5.80 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,808 Indirect Ethica Group, LLC
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.75 to $5.80, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
  2. The securities are owned directly by Ethica Group, LLC ("Ethica"). The Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica.